Disruptive Pharma AB (SE0021181559) — research page
SE · se-cm-kg/SSME/SE0021181559 · as of 2026-11-06
Identity and listing
Disruptive Pharma AB is listed on First North Sweden under the ticker SE0021181559 and ISIN SE0021181559, with LEI 549300DTX7T87FGYG180. The security type, segment, sector and jurisdiction are not on the record. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Disruptive Pharma AB | source · 2026-11-06 |
| exchange | First North Sweden | source · 2026-11-06 |
| ticker | SE0021181559 | source · 2026-11-06 |
| ISIN | SE0021181559 | source · 2026-11-06 |
| LEI | 549300DTX7T87FGYG180 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 27 filings across 24 filing days in the twelve months to 2026-11-06. The median gap between filing days is 14 days. The latest filing is dated 2026-11-02, is of type Other information disclosed according to the rules of the Exchange, and is 4 days before the record date. The First North Sweden medians are 11.0 days for cadence and 7 days for latency, across 325 issuers with a median of 21 filings. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 27 | 14 | 4 |
| exchange median: First North Sweden (325 issuers) | 21 | 11 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-02 | Other information disclosed according to the rules of the Exchange | Other information disclosed according to the rules of the Exchange | Disruptive Pharma presenterar valberedningen för 2027 |
| 2026-09-22 | Investor News | Investor News | Disruptive Pharma divests GTX platform and retains rights to future royalty and milestone revenues |
| 2026-08-20 | Half year financial report | Half year financial report | Disruptive Pharma offentliggör delårsrapport för januari-juni 2026 |
| 2026-08-18 | Investor News | Investor News | Disruptive Pharma to ring the opening bell at Nasdaq Stockholm |
| 2026-07-27 | Other information disclosed according to the rules of the Exchange | Other information disclosed according to the rules of the Exchange | Guard Therapeutics Completes Reverse Takeover of Disruptive Pharma and Executes In-Kind Share Issue |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor and its location are not on the record. The market's record does not carry auditor changes.
Events and halts
The record does not carry listing, delisting, name change, domicile change or segment move events for this market. The issuer is listed and not halted.
Orderability
The outcome is not determinable because the chapter's orderability section carries no client categories for this issuer. Rule version acm-68000/se/mifid-ii-product-governance/r1 applies, with chapter as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were named on the issuer's investor-relations pages read, and the count is 0.
Open research
One openly published research note is on the record, from Edison Investment Research dated 2026-09-08.
| date | publisher | note | kind |
|---|---|---|---|
| 2026-09-08 | Edison Investment Research | Disruptive Pharma — Reverse takeover resets the investment case | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, and the earliest sealed date for the market and the date the live record began are not on the record.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/SSME/SE0021181559 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://www.edisongroup.com/research/reverse-takeover-resets-the-investment-case/BM-3884 (open research)
- 10.7
- https://mcp.se-cm-kg.ai/record/SSME/SE0021181559 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0021181559"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:35b7353ed6eccd49.